Tunicamycin enhances the antiviral and anticellular activity of interferon. 1983

R K Maheshwari, and T Sreevalsan, and R H Silverman, and J Hay, and R M Friedman

The inhibitory effects of interferon on virus multiplication and cell growth are significantly enhanced by treatment with tunicamycin. Potentiation of antiviral activity was found only with enveloped viruses and not with nonbudding viruses. Changes in the plasma membrane of treated cells may account for this effect, since enveloped viruses bud from the cell surface as a terminal step.

UI MeSH Term Description Entries
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005944 Glucosamine 2-Amino-2-Deoxyglucose,Dona,Dona S,Glucosamine Sulfate,Hespercorbin,Xicil,2 Amino 2 Deoxyglucose,Sulfate, Glucosamine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014415 Tunicamycin An N-acetylglycosamine containing antiviral antibiotic obtained from Streptomyces lysosuperificus. It is also active against some bacteria and fungi, because it inhibits the glucosylation of proteins. Tunicamycin is used as tool in the study of microbial biosynthetic mechanisms.
D014762 Viral Interference A phenomenon in which infection by a first virus results in resistance of cells or tissues to infection by a second, unrelated virus. Interference, Viral,Interferences, Viral,Viral Interferences
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications

Related Publications

R K Maheshwari, and T Sreevalsan, and R H Silverman, and J Hay, and R M Friedman
March 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research,
R K Maheshwari, and T Sreevalsan, and R H Silverman, and J Hay, and R M Friedman
January 1981, Texas reports on biology and medicine,
R K Maheshwari, and T Sreevalsan, and R H Silverman, and J Hay, and R M Friedman
January 1977, Texas reports on biology and medicine,
R K Maheshwari, and T Sreevalsan, and R H Silverman, and J Hay, and R M Friedman
July 1983, Infection and immunity,
R K Maheshwari, and T Sreevalsan, and R H Silverman, and J Hay, and R M Friedman
January 1987, Journal of experimental pathology,
R K Maheshwari, and T Sreevalsan, and R H Silverman, and J Hay, and R M Friedman
January 1977, Archives of virology,
R K Maheshwari, and T Sreevalsan, and R H Silverman, and J Hay, and R M Friedman
January 1978, Archives of virology,
R K Maheshwari, and T Sreevalsan, and R H Silverman, and J Hay, and R M Friedman
March 1985, Japanese journal of cancer research : Gann,
R K Maheshwari, and T Sreevalsan, and R H Silverman, and J Hay, and R M Friedman
June 1981, Antiviral research,
R K Maheshwari, and T Sreevalsan, and R H Silverman, and J Hay, and R M Friedman
November 1986, Journal of pharmacobio-dynamics,
Copied contents to your clipboard!